ContractEmployment Agreement • August 8th, 2023 • Rallybio Corp • Pharmaceutical preparations • Connecticut
Contract Type FiledAugust 8th, 2023 Company Industry Jurisdiction
ContractEmployment Agreement • August 8th, 2023 • Rallybio Corp • Pharmaceutical preparations • Connecticut
Contract Type FiledAugust 8th, 2023 Company Industry Jurisdiction
EMPLOYMENT AGREEMENTEmployment Agreement • March 6th, 2023 • Rallybio Corp • Pharmaceutical preparations • Connecticut
Contract Type FiledMarch 6th, 2023 Company Industry JurisdictionEMPLOYMENT AGREEMENT (this “Agreement”) dated as of February 1, 2023 (the “Effective Date”) by and between Rallybio, LLC, a Delaware limited liability company (the “Company”), and Jonathan Lieber (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 22nd, 2021 • Rallybio Corp • Pharmaceutical preparations • Connecticut
Contract Type FiledJuly 22nd, 2021 Company Industry JurisdictionAMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) dated as of July 15, 2021 by and between Rallybio, LLC, a Delaware limited liability company (the “Company”), and Stephen Uden (the “Executive”) and effective as of the day prior to the date on which Rallybio Corporation (“Parent”) becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended (the “Securities Exchange Act”) (such date, the “Effective Date”). This Agreement amends and restates in its entirety the employment agreement by and among the Company and the Executive, effective as of April 20, 2018 (the “Prior Agreement”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 22nd, 2021 • Rallybio Corp • Pharmaceutical preparations • Connecticut
Contract Type FiledJuly 22nd, 2021 Company Industry JurisdictionAMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) dated as of July 15, 2021 by and between Rallybio, LLC, a Delaware limited liability company (the “Company”), and Martin W. Mackay (the “Executive”) and effective as of the day prior to the date on which Rallybio Corporation (“Parent”) becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended (the “Securities Exchange Act”) (such date, the “Effective Date”). This Agreement amends and restates in its entirety the employment agreement by and among the Company and the Executive, effective as of April 20, 2018 (the “Prior Agreement”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 22nd, 2021 • Rallybio Corp • Pharmaceutical preparations • Connecticut
Contract Type FiledJuly 22nd, 2021 Company Industry JurisdictionAMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) dated as of July 15, 2021 by and between Rallybio, LLC, a Delaware limited liability company (the “Company”), and Jeffrey M. Fryer (the “Executive”) and effective as of the day prior to the date on which Rallybio Corporation (“Parent”) becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended (the “Securities Exchange Act”) (such date, the “Effective Date”). This Agreement amends and restates in its entirety the employment agreement by and among the Company and the Executive, effective as of April 20, 2018 (the “Prior Agreement”).